Related Experiment Video
Updated: Mar 30, 2026

Hydra, a Computer-Based Platform for Aiding Clinicians in Cardiovascular Analysis and Diagnosis
Published on: September 26, 2018
Diagnosing hypertension: Evidence supporting the 2015 recommendations of the Canadian Hypertension Education Program
Mark Gelfer1, Martin Dawes2, Janusz Kaczorowski3
1Clinical Assistant Professor in the Department of Family Practice at the University of British Columbia in Vancouver. mgelfer@telus.net.
Insights
The 2015 Canadian Hypertension Education Program (CHEP) updated guidelines recommend electronic blood pressure (BP) measurement in clinics and out-of-office BP monitoring for accurate hypertension diagnosis and improved patient management.
Area of Science:
- Cardiology
- Preventive Medicine
- Clinical Practice Guidelines
Background:
- Accurate diagnosis of hypertension is crucial for effective management.
- Previous diagnostic methods may lead to misdiagnosis and suboptimal treatment.
- The Canadian Hypertension Education Program (CHEP) provides annual evidence-based recommendations.
Purpose of the Study:
- To present the 2015 CHEP recommendations for diagnosing and assessing hypertension.
- To guide healthcare practitioners in Canada on best practices for hypertension diagnosis.
- To improve the accuracy of hypertension diagnosis and management.
Main Methods:
- Systematic literature search conducted by a Cochrane Collaboration librarian.
- Critical appraisal of evidence by the CHEP subcommittee on BP measurement and diagnosis.
- Recommendations reviewed, graded, and approved by CHEP committees and task force.
- Evidence-based recommendations derived from Level II evidence.
Main Results:
- Four key recommendations for 2015 to enhance BP measurement and hypertension diagnosis.
- Strong recommendation for using electronic BP measurement devices in clinical settings.
- Advocacy for early out-of-office BP measurement, particularly ambulatory BP monitoring, for elevated office readings.
- Emphasis on identifying and managing white-coat hypertension.
Conclusions:
- Enhanced diagnostic accuracy is vital for optimizing hypertension care in Canada.
- CHEP's annual updates ensure practitioners receive current, evidence-based information.
- Implementation of these recommendations can lead to better hypertension management outcomes.
Objective:
To highlight the 2015 Canadian Hypertension Education Program (CHEP) recommendations for the diagnosis and assessment of hypertension.
Quality Of Evidence:
A systematic search was performed current to August 2014 by a Cochrane Collaboration librarian using the MEDLINE and PubMed databases. The search results were critically appraised by the CHEP subcommittee on blood pressure (BP) measurement and diagnosis, and evidence-based recommendations were presented to the CHEP Central Review Committee for independent review and grading. Finally, the findings and recommendations were presented to the Recommendations Task Force for discussion, debate, approval, and voting. The main recommendations are based on level II evidence.
Main Message:
Based on the most recent evidence, CHEP has made 4 recommendations in 2 broad categories for 2015 to improve BP measurement and the way hypertension is diagnosed. A strong recommendation is made to use electronic BP measurement in the office setting to replace auscultatory BP measurement. For patients with elevated office readings, CHEP is recommending early use of out-of-office BP measurement, preferably ambulatory BP measurement, in order to identify early in the process those patients with white-coat hypertension.
Conclusion:
Improvements in diagnostic accuracy are critical to optimizing hypertension management in Canada. The annual updates provided by CHEP ensure that practitioners have up-to-date evidence-based information to inform practice.
Related Concept Videos
Hypertension III: Clinical Manifestations and Diagnostic Studies
Hypertension I: Introduction
Hypertension V: Nursing Management
Hypertension and Regulation of Blood Pressure
Hypertension II: Pathophysiology
Hypertension IV: Drug Therapy and Lifestyle Modifications

